why choose us

First received: July 11, 2023

Clinical Trial: A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heart Failure With Reduced Ejection Fraction

Study Type: INTERVENTIONAL


Official Title: An Open-label, Single-sequence Study to Evaluate the Effect of Coadministration of Danicamtiv on the Pharmacokinetics of Midazolam in Patients With Stable Heart Failure With Reduced Ejection Fraction

Brief Summary: The purpose of this study is assess the effect of danicamtiv, as an inducer on the drug levels of midazolam in participants with heart failure with reduced ejection fraction (HFrEF).

Read more